Log in
0 followers
Formed in late 2017, AMLo Biosciences is dedicated to providing a prognostic test for early AJCC Stage I and Stage II melanoma to better identify patients’ true risk of disease progression.
Industries
Headquarters
Stage
Employees
Links
Marie Labus
4 members
2 members
Fios Genomics
3 followers
Sano Genetics
2 followers
evonetix
1 follower
Autolomous
BenevolentAI
6 followers
Discover companies